| Name | Gly-His-Lys |
|---|---|
| Synonyms |
Liver growth factor
Gly-L-His-L-Lys Liver cell growth factor L-Lysine, glycyl-L-histidyl- Glycyl-L-Histidyl-L-Lysine GHK Cu Copper Peptide H-Gly-His-Lys-OH glycyl-histidyl-lysine ghk Copper Peptide Ahk-cu Growth-modulating peptide Gly-His-Lys-Cu Copper Peptide (GHK-Cu) |
| Description | Glycyl-L-histidyl-L-lysine is a tripeptide consisting of glycine, L-histidine and L-lysine residues joined in sequence. Glycyl-L-histidyl-L-lysine is a hepatotropic immunosuppressor and shows anxiolytic effect. Glycyl-L-histidyl-L-lysine and its copper complexes show good skin tolerance[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Glycyl-L-histidyl-L-lysine and its copper complexes and saccharomyces/copper ferment on secretion of pro-inflammatory IL-6 in normal human dermal fibroblasts NHDF cell line[1]. Glycyl-L-histidyl-L-lysine and its copper complexes decreases TNF-α-dependent IL-6 secretion in fibroblasts[1]. |
| In Vivo | Glycyl-L-histidyl-L-lysine (intraperitoneal injection; 1.5, 5, 50, 150, and 450 mg/kg; 10 times ) can stimulate mitotic activity of hepatocytes and dose-dependently suppresse immune reactivity[2]. Glycyl-L-histidyl-L-lysine (intraperitoneal injection; 0.5, 5, and 50 μg/kg) can produce an anxiolytic effect in the elevated plus maze test[3]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 831.0±65.0 °C at 760 mmHg |
| Molecular Formula | C14H24N6O4 |
| Molecular Weight | 340.378 |
| Flash Point | 456.4±34.3 °C |
| Exact Mass | 340.185913 |
| PSA | 176.22000 |
| LogP | -2.24 |
| Vapour Pressure | 0.0±3.2 mmHg at 25°C |
| Index of Refraction | 1.583 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933290090 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |